The incidence of bronchiolitis obliterans organizing pneumonia syndrome after radiation therapy for breast cancer Source: Eur Respir J 2001; 18: Suppl. 33, 220s Year: 2001
Chronic eosinophilic pneumonia after radiation therapy for breast cancer Source: Eur Respir J 2004; 23: 9-13 Year: 2004
Organizing pneumonia in the course of Herceptin therapy for breast carcinoma Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002
Drug-induced ILD Source: Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders Year: 2007
CC7 Pneumonia, pneumonitis, or progressive disease during immunotherapy in lung cancer? Source: Milan 2017 - Educational material Year: 2017
First ever report of histologically proven bronchiolitis obliterans organizing pneumonia after antineoplastic treatment of a malignant pleural mesothelioma with cisplatin and pemetrexed Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases Year: 2011
Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia Source: Eur Respir J 2009; 33: 142-147 Year: 2009
Clinical course of pneumonia in lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 326s Year: 2005
Chronic eosinophilic pneumonia after radiation therapy for breast cancer Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011
Level of hypoferremia at patients with community-acquired pneumonia (CAP) and lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 438s Year: 2007
Treatment and prognosis of lung cancer associated with interstitial pneumonia Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan Source: ERJ Open Res, 6 (2) 00184-2019; 10.1183/23120541.00184-2019 Year: 2020
Acute lung injury as a possible adverse drug reaction related to gefitinib Source: Eur Respir J 2002 Jan 01;22(1):179-181 Year: 2003
Clinical features of organizing pneumonia primed by radiation therapy to the breast Source: Annual Congress 2008 - Imaging of different lung diseases: clinical and experimental observations Year: 2008
Lung cancer: the importance of seeing a respiratory physician Source: Eur Respir J 2003; 21: 606-610 Year: 2003
How to predict fatal pneumonitis in non-small cell lung cancer (NSCLC) patients treated with radiotherapy (RT) Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018
Characteristics, incidence, risk factors, and practical management of pneumonitis associated with anti-PD-1 immunotherapy in patients with non-small cell lung cancer Source: International Congress 2019 – Treatment of lung cancer Year: 2019
Combination therapy of gefitinib and CYP3A4 inhibitor on non-small-cell lung cancer patients with an EGFR mutation and carcinomatous meningitis Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013